International network of researchers aiming to accelerate vaccine development for TB, leishmaniasis, melioidosis &leprosy. Led by @UniofOxford - open to all
Are you a public health professional navigating complex infectious disease challenges that require a #OneHealth approach?
Join us at #TropMed26 as we explore what it takes to make One Health Collaboration work in practice.
What questions would you like to ask our panelists?
📢 REMINDER: Academy of Medical Sciences Networking Grants – Deadline 13 Nov 2026!
Find out more about this funding opportunity, eligibility, and criteria here:
🔗 acmedsci.ac.uk/grants-and-pr…
Control of M. tuberculosis infection requires CD28 to generate lung-homing T cells and CTLA-4 to limit immunopathology from @danielleobarber and colleagues: mucosalimmunology.org/articl…
🚀 WHO Updates TB Diagnostic Guidelines to Expand Access to Testing!
The World Health Organization (@WHO) has published the second edition of its consolidated TB diagnosis guidelines, introducing new recommendations to improve access to rapid, accurate and affordable tuberculosis testing.
Key updates include:
🧬 Near-point-of-care molecular testing for TB detection at peripheral health facilities.
👅 Tongue swabs as an alternative for people unable to produce sputum.
🔬 Sputum pooling to improve testing efficiency and reduce costs in resource-constrained settings.
🌍 A new WHO living website providing updated information on recommended TB diagnostic products and their prequalification status.
These developments present important opportunities to strengthen laboratory systems, expand access to quality diagnostics and accelerate efforts to end TB, particularly across Africa.
📖 Read the guidelines: who.int/publications/i/item/…#EndTB#TBDiagnostics#LaboratorySystems#GlobalHealth#HealthSecurity#ASLM
Accessing essential vaccines should never be a luxury. But for mothers in eastern Chad, getting their children protected often means enduring long, arduous travel just to reach the nearest health centre.
Here’s how a mobile clinic is revolutionising vaccine access and bringing life-saving care directly to the doorstep of remote communities: bit.ly/4irpPYi
What keeps vaccine manufacturing safe?
At the Global Training Hub for Biomanufacturing, participants explored biosafety risk assessment, protective equipment, biological material handling, and waste management to help protect people and vaccine quality.
ivi.int/ivi-launches-2026-gx…
Seed funding from Coefficient Giving will help IVI establish the BRIGHT Fund to accelerate collaborative global health innovation and expand equitable access to life-saving technologies.
🔗: ivi.int/international-vaccin…